Equine recurrent airway obstruction does not alter airway muscarinic acetylcholine receptor expression and subtype distribution.

The study aims to understand the role of muscarinic acetylcholine receptors (mAChR) in the context of equine recurrent airway obstruction (RAO). The research found no significant changes in the mAChR expression and function in horses suffering from RAO, suggesting these receptors might not be responsible for the heightened cholinergic activity often observed in this condition.

The Study Subject

• The study focused on equine recurrent airway obstruction (RAO), a chronic respiratory disease in horses. RAO, or heaves, results in bronchospasm, a constriction of the airway muscles, thought to be a consequence of enhanced cholinergic activity.

The Research Objective

• The study aimed to determine whether the enhanced cholinergic activity in RAO horses is related to changes in the expression, subtype distribution, and signaling of muscarinic acetylcholine receptors (mAChR).

Process and Findings

• The researchers examined airway tissues from nine horses with RAO and 11 healthy control horses.
• The researchers assessed the mAChR density and subtype distribution with [N-methyl-3H]-scopolamine binding ([3H]-NMS). They also evaluated the total number of high mAChR binding sites with carbachol-displacement experiments in the presence or absence of guanosine 5′-triphosphate. These investigations suggested no major alterations in mAChR in RAO, except for a trend towards receptor down-regulation in certain peripheral parts of the lung.
• To clarify whether the receptor’s functional coupling to corresponding G-proteins is intact in RAO, the researchers examined the M2-mediated inhibition of adenylate cyclase (AC) and M3-receptor-G(q/11)-phospholipase C (PLC) activity. Both were found to be unaltered in RAO compared to control airway tissues.

Conclusions

• The research concluded that in horses with RAO, the mAChR expression and function do not seem altered, suggesting that they are unlikely to be responsible for the heightened cholinergic activity typically seen in this condition.